Matches in Wikidata for { <http://www.wikidata.org/entity/Q90766432> ?p ?o ?g. }
Showing items 1 to 52 of
52
with 100 items per page.
- Q90766432 description "article scientifique publié en 2018" @default.
- Q90766432 description "artículu científicu espublizáu n'agostu de 2018" @default.
- Q90766432 description "scientific article published on 06 August 2018" @default.
- Q90766432 description "wetenschappelijk artikel" @default.
- Q90766432 description "наукова стаття, опублікована в серпні 2018" @default.
- Q90766432 name "Assessment of pioglitazone and proinflammatory cytokines during buprenorphine taper in patients with opioid use disorder" @default.
- Q90766432 name "Assessment of pioglitazone and proinflammatory cytokines during buprenorphine taper in patients with opioid use disorder" @default.
- Q90766432 type Item @default.
- Q90766432 label "Assessment of pioglitazone and proinflammatory cytokines during buprenorphine taper in patients with opioid use disorder" @default.
- Q90766432 label "Assessment of pioglitazone and proinflammatory cytokines during buprenorphine taper in patients with opioid use disorder" @default.
- Q90766432 prefLabel "Assessment of pioglitazone and proinflammatory cytokines during buprenorphine taper in patients with opioid use disorder" @default.
- Q90766432 prefLabel "Assessment of pioglitazone and proinflammatory cytokines during buprenorphine taper in patients with opioid use disorder" @default.
- Q90766432 P1433 Q90766432-8D6E30D5-D9E7-4226-AC5F-37B95636AC5E @default.
- Q90766432 P1476 Q90766432-715B212D-6087-4143-96FB-B0DF5AE112A9 @default.
- Q90766432 P2093 Q90766432-03AB65AA-7EF9-49F1-8A21-473AD7F86857 @default.
- Q90766432 P2093 Q90766432-453F99C0-EB50-4088-9BBE-61793DE141D5 @default.
- Q90766432 P2093 Q90766432-A598346C-6333-4D81-8FB0-CEBEF64FC5EA @default.
- Q90766432 P2093 Q90766432-AC36DBD1-B0B6-4C6C-B8FC-C7EE642EE116 @default.
- Q90766432 P2093 Q90766432-BC39C5B0-0263-4F9C-8D40-6534C866D4FD @default.
- Q90766432 P2093 Q90766432-C3B70909-6374-4085-BD7B-54FD778E96C4 @default.
- Q90766432 P2093 Q90766432-F0A1D7C0-59B6-44D8-80C1-92CB426A8C0E @default.
- Q90766432 P304 Q90766432-1D35C942-6D66-4DDA-B5BE-888ECA4165FC @default.
- Q90766432 P31 Q90766432-B7D6FD40-6F30-43B4-BF90-B125D777C284 @default.
- Q90766432 P356 Q90766432-04AD0B48-C5D0-4F56-B415-D9ABD229C0D9 @default.
- Q90766432 P433 Q90766432-6982E863-0689-4EF0-B519-946E371BB67F @default.
- Q90766432 P478 Q90766432-31E39CD7-6DCC-4132-8A54-01603B9878A5 @default.
- Q90766432 P50 Q90766432-ABAC1172-E138-40DE-A46F-A8913C0C3573 @default.
- Q90766432 P577 Q90766432-130E3664-0210-4A05-81AB-9640FC4608EE @default.
- Q90766432 P698 Q90766432-1C92618E-2911-46A3-B962-DB5CB341928D @default.
- Q90766432 P921 Q90766432-11CC7479-2C50-4DA4-8202-983D5BFE3C15 @default.
- Q90766432 P921 Q90766432-78303390-FFAB-4088-AFFE-642ABF0B6D9B @default.
- Q90766432 P356 S00213-018-4986-5 @default.
- Q90766432 P698 30079432 @default.
- Q90766432 P1433 Q1422802 @default.
- Q90766432 P1476 "Assessment of pioglitazone and proinflammatory cytokines during buprenorphine taper in patients with opioid use disorder" @default.
- Q90766432 P2093 "Ashley P Kennedy" @default.
- Q90766432 P2093 "David H Epstein" @default.
- Q90766432 P2093 "Jennifer R Schroeder" @default.
- Q90766432 P2093 "Karran A Phillips" @default.
- Q90766432 P2093 "Markus Heilig" @default.
- Q90766432 P2093 "Melody A Furnari" @default.
- Q90766432 P2093 "Michelle L Jobes" @default.
- Q90766432 P304 "2957-2966" @default.
- Q90766432 P31 Q13442814 @default.
- Q90766432 P356 "10.1007/S00213-018-4986-5" @default.
- Q90766432 P433 "10" @default.
- Q90766432 P478 "235" @default.
- Q90766432 P50 Q44049055 @default.
- Q90766432 P577 "2018-08-06T00:00:00Z" @default.
- Q90766432 P698 "30079432" @default.
- Q90766432 P921 Q1639178 @default.
- Q90766432 P921 Q7632070 @default.